Iovance Biotherapeutics Inc (IOVA)
10.24
-0.19
(-1.82%)
USD |
NASDAQ |
May 17, 16:00
10.15
-0.09
(-0.88%)
After-Hours: 20:00
Iovance Biotherapeutics Price to Book Value: 4.214 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 4.214 |
| May 16, 2024 | 4.292 |
| May 15, 2024 | 4.395 |
| May 14, 2024 | 4.411 |
| May 13, 2024 | 4.477 |
| May 10, 2024 | 4.512 |
| May 09, 2024 | 5.535 |
| May 08, 2024 | 5.510 |
| May 07, 2024 | 5.753 |
| May 06, 2024 | 5.712 |
| May 03, 2024 | 5.609 |
| May 02, 2024 | 5.300 |
| May 01, 2024 | 5.144 |
| April 30, 2024 | 4.848 |
| April 29, 2024 | 4.950 |
| April 26, 2024 | 4.790 |
| April 25, 2024 | 4.749 |
| April 24, 2024 | 4.819 |
| April 23, 2024 | 4.880 |
| April 22, 2024 | 4.658 |
| April 19, 2024 | 4.654 |
| April 18, 2024 | 4.823 |
| April 17, 2024 | 4.856 |
| April 16, 2024 | 4.904 |
| April 15, 2024 | 4.892 |
| Date | Value |
|---|---|
| April 12, 2024 | 5.085 |
| April 11, 2024 | 5.426 |
| April 10, 2024 | 5.175 |
| April 09, 2024 | 5.439 |
| April 08, 2024 | 5.377 |
| April 05, 2024 | 5.566 |
| April 04, 2024 | 5.595 |
| April 03, 2024 | 5.764 |
| April 02, 2024 | 5.665 |
| April 01, 2024 | 5.838 |
| March 31, 2024 | |
| March 28, 2024 | 7.080 |
| March 27, 2024 | 6.736 |
| March 26, 2024 | 6.713 |
| March 25, 2024 | 6.942 |
| March 22, 2024 | 7.176 |
| March 21, 2024 | 7.338 |
| March 20, 2024 | 7.133 |
| March 19, 2024 | 6.641 |
| March 18, 2024 | 6.703 |
| March 15, 2024 | 6.646 |
| March 14, 2024 | 6.789 |
| March 13, 2024 | 7.038 |
| March 12, 2024 | 7.033 |
| March 11, 2024 | 7.214 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.253
Minimum
Oct 19 2023
21.38
Maximum
May 22 2020
5.933
Average
4.899
Median
May 24 2019
Price to Book Value Benchmarks
| Viatris Inc | 0.6532 |
| Perspective Therapeutics Inc | 4.333 |
| Electromed Inc | 3.333 |
| Xtant Medical Holdings Inc | 1.967 |
| Asensus Surgical Inc | 5.437 |
Price to Book Value Related Metrics
| PS Ratio | 1334.72 |
| Price | 10.24 |
| Earnings Yield | -17.58% |
| Market Cap | 2.865B |